Gland Pharma

{
  "main_header": {
    "sid": 1003443,
    "name": "Gland Pharma",
    "stock_name": "Gland Pharma",
    "full_name": "Gland Pharma Ltd",
    "name_url": "stocks-analysis/gland-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,844.20",
    "chg": -27.9,
    "chgp": "-1.49%",
    "dir": -1,
    "prev_price": "1,872.10",
    "mcapval": "30,429.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543245,
    "symbol": "GLAND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE068V01023",
    "curr_date": "May 13",
    "curr_time": "",
    "bse_nse_vol": "1.07 lacs",
    "exc_status": "Active",
    "traded_date": "May 13, 2026",
    "traded_date_str": "2026 05 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gland-pharma-1003443-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gland Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-hold-by-marketsmojo-3989432",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GlandPharmaLtd_mojoScore_3989432.png",
        "date": "2026-05-13 10:10:03",
        "description": "Gland Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Gland Pharma Ltd Valuation Shifts Signal Heightened Price Attractiveness Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-valuation-shifts-signal-heightened-price-attractiveness-amid-sector-dynamics-3984739",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GlandPharmaLtd_valuationdot_3984739.png",
        "date": "2026-05-11 08:02:34",
        "description": "Gland Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, reflecting evolving market perceptions and price attractiveness. Despite this, the company’s recent performance and sector context suggest a nuanced investment outlook for this pharmaceuticals and biotechnology small-cap."
      },
      {
        "title": "Gland Pharma Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-to-mildly-bullish-amid-mixed-indicators-3976991",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GlandPharmaLtd_technicaldot_3976991.png",
        "date": "2026-05-06 08:06:14",
        "description": "Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance on weekly charts, despite a recent 2.43% decline in its share price. This nuanced change is underscored by a complex interplay of technical indicators, reflecting both optimism and caution among investors in the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3974989",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GlandPharmaLtd_technicaldot_3974989.png",
        "date": "2026-05-05 08:07:29",
        "description": "Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. This transition comes amid a strong price performance that outpaces the broader Sensex, signalling renewed investor interest in the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3973813",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GlandPharmaLtd_technicaldot_3973813.png",
        "date": "2026-05-04 08:02:31",
        "description": "Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite this, key indicators such as the MACD and KST suggest a nuanced outlook, with weekly signals showing mild bullishness contrasting with monthly bearish tendencies. This complex technical landscape warrants close attention from investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Gland Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-hold-3972597",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GlandPharmaLtd_mojoScore_3972597.png",
        "date": "2026-05-02 10:10:25",
        "description": "Gland Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Mar 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Gland Pharma Ltd Technical Momentum Shifts to Sideways; Hold Rating Upgraded",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-to-sideways-hold-rating-upgraded-3965705",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GlandPharmaLtd_technicaldot_3965705.png",
        "date": "2026-04-28 08:06:01",
        "description": "Gland Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more neutral sideways trend, reflecting a cautious optimism among investors. The stock’s recent 3.44% gain to ₹1,773.30, coupled with mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggests a complex interplay of bullish and bearish forces shaping its near-term trajectory."
      },
      {
        "title": "Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3963709",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GlandPharmaLtd_technicaldot_3963709.png",
        "date": "2026-04-27 08:02:44",
        "description": "Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance as of late April 2026. Despite a recent downgrade in its Mojo Grade from Sell to Hold, the stock’s mixed technical indicators and price action suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Gland Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-hold-3955812",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GlandPharmaLtd_mojoScore_3955812.png",
        "date": "2026-04-21 10:10:33",
        "description": "Gland Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 377,
    "sid": "1003443",
    "stock_news_url": "https://www.marketsmojo.com/news/gland-pharma-1003443"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "15 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gland Pharma Ltd has declared <strong>1800%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Gland Pharma Ltd is Rated Hold by MarketsMOJO

2026-05-13 10:10:03

Gland Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Gland Pharma Ltd Valuation Shifts Signal Heightened Price Attractiveness Amid Sector Dynamics

2026-05-11 08:02:34

Gland Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, reflecting evolving market perceptions and price attractiveness. Despite this, the company’s recent performance and sector context suggest a nuanced investment outlook for this pharmaceuticals and biotechnology small-cap.

Read full news article

Gland Pharma Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators

2026-05-06 08:06:14

Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance on weekly charts, despite a recent 2.43% decline in its share price. This nuanced change is underscored by a complex interplay of technical indicators, reflecting both optimism and caution among investors in the pharmaceuticals and biotechnology sector.

Read full news article

Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-05 08:07:29

Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. This transition comes amid a strong price performance that outpaces the broader Sensex, signalling renewed investor interest in the pharmaceuticals and biotechnology sector.

Read full news article

Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-04 08:02:31

Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite this, key indicators such as the MACD and KST suggest a nuanced outlook, with weekly signals showing mild bullishness contrasting with monthly bearish tendencies. This complex technical landscape warrants close attention from investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Gland Pharma Ltd is Rated Hold

2026-05-02 10:10:25

Gland Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Mar 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read full news article

Gland Pharma Ltd Technical Momentum Shifts to Sideways; Hold Rating Upgraded

2026-04-28 08:06:01

Gland Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more neutral sideways trend, reflecting a cautious optimism among investors. The stock’s recent 3.44% gain to ₹1,773.30, coupled with mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggests a complex interplay of bullish and bearish forces shaping its near-term trajectory.

Read full news article

Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-27 08:02:44

Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance as of late April 2026. Despite a recent downgrade in its Mojo Grade from Sell to Hold, the stock’s mixed technical indicators and price action suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Gland Pharma Ltd is Rated Hold

2026-04-21 10:10:33

Gland Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News